Fouassier, Laura <br/><br/>
Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan.  [electronic resource] 

 -  Journal of hepatology  Aug 2002 
 - 184-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0168-8278 
<br/><br/><label>Standard No.: </label>10.1016/s0168-8278(02)00107-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Bile Acids and Salts--metabolism<br/>Bile Canaliculi--drug effects<br/>Bilirubin--metabolism<br/>Bosentan<br/>Cholesterol--metabolism<br/>Endothelin Receptor Antagonists<br/>Male<br/>Membrane Transport Proteins<br/>Multidrug Resistance-Associated Protein 2<br/>Multidrug Resistance-Associated Proteins--metabolism<br/>Phospholipids--metabolism<br/>Rats<br/>Rats, Mutant Strains<br/>Rats, Sprague-Dawley<br/>Rats, Wistar<br/>Receptor, Endothelin A<br/>Receptor, Endothelin B<br/>Sulfonamides--pharmacology